The Global report “Cell Culture Market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing at a CAGR of 13.4% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Growth of the market can be attributed to factors such as growing focus on single-use technologies, increasing demand for novel therapeutics due to rising incidence of chronic diseases, and growth in biotechnology industry. However, high cost of cell biology research may hamper the growth of the market.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559
Browse in-depth TOC on “Cell Culture Market”
997 – Tables
54 – Figures
772 – Pages
Key Market Players:
Key players in the cell culture market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US) Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).
DRIVER: Increasing fundings for cell-based research
Cell culture is integral in developing biological products to combat diseases like cancer and cardiovascular ailments. Globally, significant R&D efforts, backed by both governmental and private entities, are focused on pioneering cell therapy solutions. For instance, CellVovant, a biotech firm affiliated with the University of Bristol, secured USD 9.55 million (GBP 7.6 million) seed funding in January 2021 to accelerate the development of innovative stem cell therapies. Moreover, collaborations between public and private sectors are driving advancements; examples include research funding from organizations like the Ovarian Cancer Research Alliance and the European Research Council for investigating stem cell-based treatments for various diseases. With increasing research and funding directed towards addressing autoimmune, neurological, and cardiovascular disorders, the cell therapy market is poised for significant expansion.
RESTRAINT: High cost of cell biology research
Cell biology research, encompassing cutting-edge therapies like stem cell and gene therapies, demands top-tier equipment and reagents to ensure precise outcomes. As the need for stringent quality control and regulatory compliance rises, the cost of conducting cell biology research has significantly surged. The expensive nature of this research, coupled with budget constraints faced by researchers and small-scale pharmaceutical companies, poses hurdles in adopting microcarrier-based technologies for large-scale cell culture. These financial barriers impede the growth of the market, deterring potential adopters and customers.
Request Free Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559
The consumables segment accounted for the largest share of the product segment in the cell culture market in 2023.
Based on products, the cell culture market is segmented into consumables and equipment. Consumables are further segmented into sera, media, reagents; vessels; and accessories. Equipment is further categorized as bioreactors, storage equipment, and other equipment. Consumables segment dominated the market in 2023 and is expected to grow at a higher rate during the forecast. The largest share of the segment is attributed to repetitive purchase of media & reagents, and growing R&D activities to develop and manufacture advanced therapies.
The pharmaceutical and biotechnology companies’ segment is estimated to register the highest growth rate during the forecast period in the cell culture market.
Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies’ segment is estimated to register the highest growth rate during the forecast period. The rising demand for advanced therapies such as regenerative medicine due to increasing prevalence of chronic diseases is expected to boost the growth of pharmaceutical & biotechnology companies’ segment in coming years.
Request 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=559
Recent Developments of Cell Culture Industry:
- In September 2023, Thermo Fisher Scientific launched the Gibco CTS Detachable Dynabeads, a groundbreaking platform with an innovative active-release mechanism designed for the clinical and commercial operation of cell therapy manufacturing.
- In December 2023, Danaher acquired Abcam, a provider of validated antibodies, reagents, biomarkers, and assays crucial for drug discovery, life sciences research, and diagnostics. Within Danaher’s Life Sciences segment, Abcam will continue to operate independently, aligning with Danaher’s mission to advance disease understanding and expedite drug discovery.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
